UBS increased its price target for Oracle (ORCL) shares to $285 from $250. The firm reaffirmed its "Buy" rating on the stock. This adjustment precedes Oracle's fourth-quarter earnings report, expected next week.
The investment bank's positive outlook cites sustained momentum in Oracle's business, particularly in artificial intelligence. Analyst Karl Keirstead found no evidence of a setback in the company's growth trajectory after checking with large customers and partners. UBS remains confident in Oracle's position within the broader AI infrastructure market.